Your Messages Inbox
Your Article Summary
See Latest ArticlesUpdate on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 09/21/09
Chugai Pharmaceutical Co., Ltd. announced that FDA has accepted the complete response resubmission that Roche made to the U.S. Food and Drug Administration for the Biologics License Application for Actemra the humanized anti–human IL–6 receptor monoclonal antibody, following the receipt of the Complete Response Letter in September 2008.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor